By proceeding, you agree to our Terms of Use and Privacy Policy.
An experienced molecular and cellular biologist who has served as scientific lead to successfully take a drug development program from early discovery to development.
Talks About #biotechnology #drugdevelopment
Preferred Locations #Northamerica
The surge of clinical approvals in CKD and unprecedented use of surrogate endpoints in rare kidney diseases have catalysed a new era of complimentary therapies and precision medicine in drug development for kidney disease.
